Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.608, 2010-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tamoxifen plus chemotherapy worth it in early breast cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. :
Tamoxifen plus chemotherapy worth it in early breast cancer?
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :
Is early intervention with biological agents worthwhile in RA?
Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. :
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 280, 2000-01 ,pp. :
Are clinical trials worth it to insurers?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. :